Concentra Group Holdings Parent, Inc. (CON) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
CON currently has 128M outstanding shares. with moderate dilution risk from 25.9M authorized shares representing 20.1% potential dilution. The company has significantly diluted shareholders by 29.16% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 128.5M shares outstanding |
130M | 26M |
| Nov 06, 2025 |
10-Q filing | 128.2M shares outstanding |
130M | 26M |
| Aug 07, 2025 |
10-Q filing | 128.2M shares outstanding |
130M | 26M |
| May 07, 2025 |
10-Q filing | 126.6M shares outstanding |
130M | 26M |
| Mar 03, 2025 |
10-K filing | 128.1M shares outstanding |
130M | 26M |
| Nov 06, 2024 |
10-Q filing | 120.8M shares outstanding |
120M | 26M |
| Aug 27, 2024 |
10-Q filing | 126.6M shares outstanding |
130M | 26M |
| Aug 01, 2024 |
8-K filing: Concentra Group Holdings Parent, Inc. completed its initial public offering of 22,500,000 shares of its common stock at $23.50 per share, resulting in net proceeds of $499,668,750.00, and entered into a separation agreement and related agreements with Select Medical Corporation. ($499.67M proceeds) |
100M | 26M |
| Jul 24, 2024 |
S-1/A filing: This S-1/A filing describes an offering of common stock with an underwriters' option to purchase additional shares. The company intends to use the net proceeds to repay debt to SMC. |
130M | 26M |
| Jul 15, 2024 |
S-1/A filing: This S-1/A filing describes an offering of common stock and grants underwriters an option to purchase additional shares, with the net proceeds primarily intended to repay intercompany notes. |
130M | 26M |
| Jun 14, 2024 |
S-1 filing: S-1 filing for an IPO including an underwriter option to purchase additional shares. |
N/A | 0 |